TIEFENBACHER GROUP becomes member of the Pharmaceutical Supply Chain Initiative (PSCI)

We at TIEFENBACHER GROUP are committed to promote sustainable and responsible business along the whole pharmaceutical supply chain. That’s why we are excited to become a member of PSCI – a non-profit business membership organization striving for better social, health, safety, and environmental outcomes in pharmaceutical supply chains. It follows our company´s strategy to make medicines better affordable, better available, and better than before in a sustainable way – better for people and the planet!

PSCI is a group of international pharmaceutical and healthcare companies who share together the vision of responsible supply chains. The organization was founded in 2006 and is legally established in the United States. Today PSCI already counts 63 members. For more information about the organization have a look at: PSCI (pscinitiative.org) .

TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world. We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email at  info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com